Translational and clinical cancer research plays a vital role in turning laboratory discoveries into real-world medical treatments. This field focuses on applying insights from basic science to develop novel therapies, aiming to enhance the quality of patient care. It encompasses the exploration of cancer mechanisms, the identification of potential biomarkers, and the testing of treatments through clinical trials. By bridging the gap between research and patient care, this approach fosters the creation of targeted therapies that are both innovative and personalized. As a result, translational and clinical research accelerates the delivery of cutting-edge cancer treatments to patients in need.
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title :
Jianhua Luo, University of Pittsburgh, United States
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title :
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates